-In patients with symptomatic peripheral artery disease (PAD) with a history of limb revascularization, the optimal antithrombotic regimen for long-term management is unknown
BACKGROUND: High-quality evidence from trials directly comparing single antiplatelet therapies in sy...
OBJECTIVE: Transcarotid artery revascularization (TCAR) with dynamic flow reversal is a hybrid techn...
BACKGROUND Acute limb ischemia (ALI) is an important clinical event and an emerging cardiovascula...
-In patients with symptomatic peripheral artery disease (PAD) with a history of limb revascularizati...
Background: In patients with symptomatic peripheral artery disease with a history of limb revascular...
BACKGROUND -In patients with symptomatic peripheral artery disease (PAD) with a history of limb r...
Background: Peripheral artery disease is considered to be a manifestation of systemic atherosclerosi...
Patients with peripheral artery disease (PAD) are at heightened risk of cardiovascular morbidity and...
Background Peripheral artery disease is considered to be a manifestation of systemic atherosclerosis...
A critical appraisal and clinical application of Hiatt H, Fowkes G, Heizer G, et al. Ticagrelor vers...
OBJECTIVES: The aim of this study was to investigate the optimal strategy for antiplatelet therapy...
BACKGROUND Despite overwhelming data demonstrating the efficacy of antiplatelet therapy in heart ...
© 2019 American Heart Association, Inc. BACKGROUND: Acute limb ischemia (ALI) is an important clinic...
Peripheral artery disease affects >200 million people worldwide and is associated with significant l...
A systematic literature review was conducted to identify and summarize the clinical efficacy and saf...
BACKGROUND: High-quality evidence from trials directly comparing single antiplatelet therapies in sy...
OBJECTIVE: Transcarotid artery revascularization (TCAR) with dynamic flow reversal is a hybrid techn...
BACKGROUND Acute limb ischemia (ALI) is an important clinical event and an emerging cardiovascula...
-In patients with symptomatic peripheral artery disease (PAD) with a history of limb revascularizati...
Background: In patients with symptomatic peripheral artery disease with a history of limb revascular...
BACKGROUND -In patients with symptomatic peripheral artery disease (PAD) with a history of limb r...
Background: Peripheral artery disease is considered to be a manifestation of systemic atherosclerosi...
Patients with peripheral artery disease (PAD) are at heightened risk of cardiovascular morbidity and...
Background Peripheral artery disease is considered to be a manifestation of systemic atherosclerosis...
A critical appraisal and clinical application of Hiatt H, Fowkes G, Heizer G, et al. Ticagrelor vers...
OBJECTIVES: The aim of this study was to investigate the optimal strategy for antiplatelet therapy...
BACKGROUND Despite overwhelming data demonstrating the efficacy of antiplatelet therapy in heart ...
© 2019 American Heart Association, Inc. BACKGROUND: Acute limb ischemia (ALI) is an important clinic...
Peripheral artery disease affects >200 million people worldwide and is associated with significant l...
A systematic literature review was conducted to identify and summarize the clinical efficacy and saf...
BACKGROUND: High-quality evidence from trials directly comparing single antiplatelet therapies in sy...
OBJECTIVE: Transcarotid artery revascularization (TCAR) with dynamic flow reversal is a hybrid techn...
BACKGROUND Acute limb ischemia (ALI) is an important clinical event and an emerging cardiovascula...